|
1
|
Deans C and Wigmore SJ: Systemic
inflammation, cachexia and prognosis in patients with cancer. Curr
Opin Clin Nutr Metab Care. 8:265–269. 2005.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ridker PM: Inflammatory biomarkers and
risks of myocardial infarction, stroke, diabetes, and total
mortality: Implications for longevity. Nutr Rev. 65
(Suppl):S253–S259. 2007.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cray C, Zaias J and Altman NH: Acute phase
response in animals: A review. Comp Med. 59:517–526.
2009.PubMed/NCBI
|
|
4
|
Boosalis MG, Snowdon DA, Tully CL and
Gross MD: Acute phase response and plasma carotenoid concentrations
in older women: Findings from the nun study. Nutrition. 12:475–478.
1996.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mackiewicz A: Acute phase proteins and
transformed cells. Int Rev Cytol. 170:225–300. 1997.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Koj A: Termination of acute-phase
response: Role of some cytokines and anti-inflammatory drugs. Gen
Pharmacol. 31:9–18. 1998.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ceron JJ, Eckersall PD and
Martynez-Subiela S: Acute phase proteins in dogs and cats: Current
knowledge and future perspectives. Vet Clin Pathol. 34:85–99.
2005.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gómez-Laguna J, Salguero FJ, Pallarés
FJ, Rodríguez-Gómez IM, Barranco I and Carrasco L: Acute phase
proteins as biomarkers in animal health and welfare. In: Acute
Phase Proteins As Early Non-Specific Biomarkers of Human and
Veterinary Diseases. Veas F (ed). InTech, pp259-298, 2011.
|
|
9
|
Sharpe-Timms KL, Nabli H, Zimmer RL, Birt
JA and Davis JW: Inflammatory cytokines differentially up-regulate
human endometrial haptoglobin production in women with
endometriosis. Hum Reprod. 25:1241–1250. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Suk HJ, Ridker PM, Cook NR and Zee RY:
Relation of polymorphism within the C-reactive protein gene and
plasma CRP levels. Atherosclerosis. 178:139–145. 2005.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Macleod CM and Avery OT: The occurrence
during acute infections of a protein not normally present in the
blood: II. Isolation and properties of the reactive protein. J Exp
Med. 73:183–190. 1941.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ballou SP and Kushner I: C-reactive
protein and the acute phase response. Adv Intern Med. 37:313–336.
1992.PubMed/NCBI
|
|
13
|
Anderson HC and McCarty M: The occurrence
in the rabbit of an acute phase protein analogous to human C
reactive protein. J Exp Med. 93:25–36. 1951.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Mold C, Rodriguez W, Rodic-Polic B and Du
Clos TW: C-reactive protein mediates protection from
lipopolysaccharide through interactions with Fc gamma R. J Immunol.
169:7019–7025. 2002.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Volanakis JE and Kaplan MH: Specificity of
C-reactive protein for choline phosphate residues of pneumococcal
C-polysaccharide. Proc Soc Exp Biol Med. 136:612–614.
1971.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gabay C and Kushner I: Acute-phase
proteins and other systemic responses to inflammation. N Engl J
Med. 340:448–454. 1999.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Volanakis JE: Acute phase proteins in
rheumatic disease. In: Arthritis and allied conditions: A textbook
of rheumatology. Koopman WJ (ed). 13 edition. Williams &
Wilkins, Baltimore, MD, pp505-514, 1997.
|
|
18
|
Rao AK, Chouhan V, Chen X, Sun L and Boden
G: Activation of the tissue factor pathway of blood coagulation
during prolonged hyperglycemia in young healthy men. Diabetes.
48:1156–1161. 1999.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Stegenga ME, van der Crabben SN, Levi M,
de Vos AF, Tanck MW, Sauerwein HP and van der Poll T: Hyperglycemia
stimulates coagulation, whereas hyperinsulinemia impairs
fibrinolysis in healthy humans. Diabetes. 55:1807–1812.
2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Pepys MB and Hirschfield GM: C-reactive
protein: A critical update. J Clin Invest. 111:1805–1812.
2003.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Falsey AR, Walsh EE, Francis CW, Looney
RJ, Kolassa JE, Hall WJ and Abraham GN: Response of C-reactive
protein and serum amyloid A to influenza A infection in older
adults. J Infect Dis. 183:995–999. 2001.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Woloshin S and Schwartz LM: Distribution
of C-reactive protein values in the United States. N Engl J Med.
352:1611–1613. 2005.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yen-Watson B and Kushner I: Rabbit CRP
response to endotoxin administration: Dose-response relationship
and kinetics. Proc Soc Exp Biol Med. 146:1132–1136. 1974.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Langlois MR and Delanghe JR: Biological
and clinical significance of haptoglobin polymorphism in humans.
Clin Chem. 42:1589–1600. 1996.PubMed/NCBI
|
|
25
|
Bowman BH and Kurosky A: Haptoglobin: The
evolutionary product of duplication, unequal crossing over, and
point mutation. Adv Hum Genet. 12:189–261, 453-184. 1982.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Alayash AI: Redox biology of blood.
Antioxid Redox Signal. 6:941–943. 2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Eklund KK, Niemi K and Kovanen PT: Immune
functions of serum amyloid A. Crit Rev Immunol. 32:335–348.
2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Minneci PC, Deans KJ, Zhi H, Yuen PS, Star
RA, Banks SM, Schechter AN, Natanson C, Gladwin MT and Solomon SB:
Hemolysis-associated endothelial dysfunction mediated by
accelerated NO inactivation by decompartmentalized oxyhemoglobin. J
Clin Invest. 115:3409–3417. 2005.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gilstad CW: Anaphylactic transfusion
reactions. Curr Opin Hematol. 10:419–423. 2003.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Larsen K, Macleod D, Nihlberg K, Gurcan E,
Bjermer L, Marko-Varga G and Westergren-Thorsson G: Specific
haptoglobin expression in bronchoalveolar lavage during
differentiation of circulating fibroblast progenitor cells in mild
asthma. J Proteome Res. 5:1479–1483. 2006.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Shimada E, Tadokoro K, Watanabe Y, Ikeda
K, Niihara H, Maeda I, Isa K, Moriya S, Ashida T, Mitsunaga S, et
al: Anaphylactic transfusion reactions in haptoglobin-deficient
patients with IgE and IgG haptoglobin antibodies. Transfusion.
42:766–773. 2002.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Arredouani M, Matthijs P, Van Hoeyveld E,
Kasran A, Baumann H, Ceuppens JL and Stevens E: Haptoglobin
directly affects T cells and suppresses T helper cell type 2
cytokine release. Immunology. 108:144–151. 2003.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Saeed SA, Ahmad N and Ahmed S: Dual
inhibition of cyclooxygenase and lipoxygenase by human haptoglobin:
Its polymorphism and relation to hemoglobin binding. Biochem
Biophys Res Commun. 353:915–920. 2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Pepys MB, Dash AC, Markham RE, Thomas HC,
Williams BD and Petrie A: Comparative clinical study of protein SAP
(amyloid P component) and C-reactive protein in serum. Clin Exp
Immunol. 32:119–124. 1978.PubMed/NCBI
|
|
35
|
Derebe MG, Zlatkov CM, Gattu S, Ruhn KA,
Vaishnava S, Diehl GE, MacMillan JB, Williams NS and Hooper LV:
Serum amyloid A is a retinol binding protein that transports
retinol during bacterial infection. Elife. 3(e03206)2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Bottazzi B, Doni A, Garlanda C and
Mantovani A: An integrated view of humoral innate immunity:
Pentraxins as a paradigm. Annu Rev Immunol. 28:157–183.
2010.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Hind CR, Collins PM, Renn D, Cook RB,
Caspi D, Baltz ML and Pepys MB: Binding specificity of serum
amyloid P component for the pyruvate acetal of galactose. J Exp
Med. 159:1058–1069. 1984.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Loveless RW, Floyd-O'Sullivan G, Raynes
JG, Yuen CT and Feizi T: Human serum amyloid P is a multispecific
adhesive protein whose ligands include 6-phosphorylated mannose and
the 3-sulphated saccharides galactose, N-acetylgalactosamine and
glucuronic acid. EMBO J. 11:813–819. 1992.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Familian A, Zwart B, Huisman HG, Rensink
I, Roem D, Hordijk PL, Aarden LA and Hack CE: Chromatin-independent
binding of serum amyloid P component to apoptotic cells. J Immunol.
167:647–654. 2001.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Husby G, Marhaug G, Dowton B, Sletten K
and Sipe JD: Serum amyloid A (SAA): Biochemistry, genetics and the
pathogenesis of AA amyloidosis. Int J Exu Clin Invest. 1:119–137.
1994. View Article : Google Scholar
|
|
41
|
Wang S, Murphy CL, Kestler D, Macy SD,
Williams TK, Weiss DT and Solomon A: SAA4-related AA amyloidosis.
In: XIth International Symposium on Amyloidosis. CRC Press, Boca
Raton, FL, 2008.
|
|
42
|
Eriksen N and Benditt EP: Isolation and
characterization of the amyloid-related apoprotein (SAA) from human
high density lipoprotein. Proc Natl Acad Sci USA. 77:6860–6864.
1980.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Levy JH, Szlam F, Tanaka KA and
Sniecienski RM: Fibrinogen and hemostasis: A primary hemostatic
target for the management of acquired bleeding. Anesth Analg.
114:261–274. 2012.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Jennewein C, Tran N, Paulus P, Ellinghaus
P, Eble JA and Zacharowski K: Novel aspects of fibrin(ogen)
fragments during inflammation. Mol Med. 17:568–573. 2011.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Mosesson MW: Fibrinogen and fibrin
structure and functions. J Thromb Haemost. 3:1894–1904.
2005.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Meyer MA, Ostrowski SR, Windelov NA and
Johansson PI: Fibrinogen concentrates for bleeding trauma patients:
What is the evidence? Vox Sang. 101:185–190. 2011.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Furie B and Furie BC: The molecular basis
of blood coagulation. Cell. 53:505–518. 1988.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Colvin RB, Johnson RA, Mihm MC Jr and
Dvorak HF: Role of the clotting system in cell-mediated
hypersensitivity. I. Fibrin deposition in delayed skin reactions in
man. J Exp Med. 138:686–698. 1973.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Labarrere CA, Nelson DR and Faulk WP:
Myocardial fibrin deposits in the first month after transplantation
predict subsequent coronary artery disease and graft failure in
cardiac allograft recipients. Am J Med. 105:207–213.
1998.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Ryden L and Eaker D: Identification of the
thiol groups in human ceruloplasmin. Eur J Biochem. 132:241–247.
1983.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Jamieson GA: Studies on Glycoproteins. I.
The carbohydrate portion of human ceruloplasmin. J Biol Chem.
240:2019–2027. 1965.PubMed/NCBI
|
|
52
|
Harris ZL, Klomp LW and Gitlin JD:
Aceruloplasminemia: An inherited neurodegenerative disease with
impairment of iron homeostasis. Am J Clin Nutr. 67 (5
Suppl):972S–977S. 1998.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Colombo S, Buclin T, Decosterd LA, Telenti
A, Furrer H, Lee BL, Biollaz J and Eap CB: Swiss HIV Cohort Study:
Orosomucoid (alpha1-acid glycoprotein) plasma concentration and
genetic variants: Effects on human immunodeficiency virus protease
inhibitor clearance and cellular accumulation. Clin Pharmacol Ther.
80:307–318. 2006.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Osaki S, Johnson DA and Frieden E: The
possible significance of the ferrous oxidase activity of
ceruloplasmin in normal human serum. J Biol Chem. 241:2746–2751.
1966.PubMed/NCBI
|
|
55
|
Osaki S, Johnson DA and Frieden E: The
mobilization of iron from the perfused mammalian liver by a serum
copper enzyme, ferroxidase I. J Biol Chem. 246:3018–3023.
1971.PubMed/NCBI
|
|
56
|
Attieh ZK, Mukhopadhyay CK, Seshadri V,
Tripoulas NA and Fox PL: Ceruloplasmin ferroxidase activity
stimulates cellular iron uptake by a trivalent cation-specific
transport mechanism. J Biol Chem. 274:1116–1123. 1999.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Harris ZL, Takahashi Y, Miyajima H,
Serizawa M, MacGillivray RT and Gitlin JD: Aceruloplasminemia:
Molecular characterization of this disorder of iron metabolism.
Proc Natl Acad Sci USA. 92:2539–2543. 1995.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Lahey ME, Gubler CJ, Chase MS, Cartwright
GE and Wintrobe MM: Studies on copper metabolism. II. Hematologic
manifestations of copper deficiency in swine. Blood. 7:1053–1074.
1952.PubMed/NCBI
|
|
59
|
Hochepied T, Berger FG, Baumann H and
Libert C: Alpha(1)-acid glycoprotein: An acute phase protein with
inflammatory and immunomodulating properties. Cytokine Growth
Factor Rev. 14:25–34. 2003.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Giurgea N, Constantinescu MI, Stanciu R,
Suciu S and Muresan A: Ceruloplasmin-acute-phase reactant or
endogenous antioxidant? The case of cardiovascular disease. Med Sci
Monit. 11:RA48–RA51. 2005.PubMed/NCBI
|
|
61
|
Gutteridge JM: Caeruloplasmin: A plasma
protein, enzyme, and antioxidant. Ann Clin Biochem. 15:293–296.
1978.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Mukhopadhyay CK, Ehrenwald E and Fox PL:
Ceruloplasmin enhances smooth muscle cell- and endothelial
cell-mediated low density lipoprotein oxidation by a
superoxide-dependent mechanism. J Biol Chem. 271:14773–14778.
1996.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Mukhopadhyay CK, Mazumder B, Lindley PF
and Fox PL: Identification of the prooxidant site of human
ceruloplasmin: A model for oxidative damage by copper bound to
protein surfaces. Proc Natl Acad Sci USA. 94:11546–11551.
1997.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Smolarczyk K, Gils A, Boncela J, Declerck
PJ and Cierniewski CS: Function-stabilizing mechanism of
plasminogen activator inhibitor type 1 induced upon binding to
alpha1-acid glycoprotein. Biochemistry. 44:12384–12390.
2005.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Geboes K, Ray MB, Rutgeerts P, Callea F,
Desmet VJ and Vantrappen G: Morphological identification of
alpha-I-antitrypsin in the human small intestine. Histopathology.
6:55–60. 1982.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Kremer JM, Wilting J and Janssen LH: Drug
binding to human alpha-1-acid glycoprotein in health and disease.
Pharmacol Rev. 40:1–47. 1988.PubMed/NCBI
|
|
67
|
Barraud B, Balavoine S, Feldmann G and
Lardeux B: Effects of insulin, dexamethasone and cytokines on alpha
1-acid glycoprotein gene expression in primary cultures of normal
rat hepatocytes. Inflammation. 20:191–202. 1996.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Mejdoubi N, Henriques C, Bui E, Durand G,
Lardeux B and Porquet D: Growth hormone inhibits rat liver
alpha-1-acid glycoprotein gene expression in vivo and in vitro.
Hepatology. 29:186–194. 1999.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Costello MJ, Gewurz H and Siegel JN:
Inhibition of neutrophil activation by alpha1-acid glycoprotein.
Clin Exp Immunol. 55:465–472. 1984.PubMed/NCBI
|
|
70
|
Laine E, Couderc R, Roch-Arveiller M,
Vasson MP, Giroud JP and Raichvarg D: Modulation of human
polymorphonuclear neutrophil functions by alpha 1-acid
glycoprotein. Inflammation. 14:1–9. 1990.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Tilg H, Vannier E, Vachino G, Dinarello CA
and Mier JW: Antiinflammatory properties of hepatic acute phase
proteins: Preferential induction of interleukin 1 (IL-1) receptor
antagonist over IL-1 beta synthesis by human peripheral blood
mononuclear cells. J Exp Med. 178:1629–1636. 1993.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Samak R, Edelstein R and Israel L:
Immunosuppressive effect of acute-phase reactant proteins in vitro
and its relevance to cancer. Cancer Immunol Immunother. 13:38–43.
1982.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Muchitsch EM, Teschner W, Linnau Y and
Pichler L: In vivo effect of alpha 1-acid glycoprotein on
experimentally enhanced capillary permeability in guinea-pig skin.
Arch Int Pharmacodyn Ther. 331:313–321. 1996.PubMed/NCBI
|
|
74
|
Perlmutter DH, Kay RM, Cole FS, Rossing
TH, Van Thiel D and Colten HR: The cellular defect in alpha
1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in
human monocytes and in Xenopus oocytes injected with human liver
mRNA. Proc Natl Acad Sci USA. 82:6918–6921. 1985.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Ray MB, Geboes K, Callea F and Desmet VJ:
Alpha-1-antitrypsin immunoreactivity in gastric carcinoid.
Histopathology. 6:289–297. 1982.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Berman MB, Barber JC, Talamo RC and
Langley CE: Corneal ulceration and the serum antiproteases. I.
Alpha 1-antitrypsin. Invest Ophthalmol. 12:759–770. 1973.PubMed/NCBI
|
|
77
|
Chowanadisai W and Lonnerdal B:
Alpha(1)-antitrypsin and antichymotrypsin in human milk: Origin,
concentrations, and stability. Am J Clin Nutr. 76:828–833.
2002.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Huang CM: Comparative proteomic analysis
of human whole saliva. Arch Oral Biol. 49:951–962. 2004.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Janciauskiene S, Toth E, Sahlin S and
Eriksson S: Immunochemical and functional properties of biliary
alpha-1-antitrypsin. Scand J Clin Lab Invest. 56:597–608.
1996.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Poortmans J and Jeanloz RW: Quantitative
immunological determination of 12 plasma proteins excreted in human
urine collected before and after exercise. J Clin Invest.
47:386–393. 1968.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Boskovic G and Twining SS: Retinol and
retinaldehyde specifically increase alpha1-proteinase inhibitor in
the human cornea. Biochem J. 322:751–756. 1997.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Lonnerdal B and Iyer S: Lactoferrin:
Molecular structure and biological function. Annu Rev Nutr.
15:93–110. 1995.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Garcia-Montoya IA, Cendon TS,
Arevalo-Gallegos S and Rascon-Cruz Q: Lactoferrin a multiple
bioactive protein: An overview. Biochim Biophys Acta. 1820:226–236.
2012.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Singh PK, Parsek MR, Greenberg EP and
Welsh MJ: A component of innate immunity prevents bacterial biofilm
development. Nature. 417:552–555. 2002.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Vogel HJ: Lactoferrin, a bird's eye view.
Biochem Cell Biol. 90:233–244. 2012.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Guntupalli K, Dean N, Morris PE, Bandi V,
Margolis B, Rivers E, Levy M, Lodato RF, Ismail PM, Reese A, et al:
A phase 2 randomized, double-blind, placebo-controlled study of the
safety and efficacy of talactoferrin in patients with severe
sepsis. Crit Care Med. 41:706–716. 2013.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Digumarti R, Wang Y, Raman G, Doval DC,
Advani SH, Julka PK, Parikh PM, Patil S, Nag S, Madhavan J, et al:
A randomized, double-blind, placebo-controlled, phase II study of
oral talactoferrin in combination with carboplatin and paclitaxel
in previously untreated locally advanced or metastatic non-small
cell lung cancer. J Thorac Oncol. 6:1098–1103. 2011.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Parikh PM, Vaid A, Advani SH, Digumarti R,
Madhavan J, Nag S, Bapna A, Sekhon JS, Patil S, Ismail PM, et al:
Randomized, double-blind, placebo-controlled phase II study of
single-agent oral talactoferrin in patients with locally advanced
or metastatic non-small-cell lung cancer that progressed after
chemotherapy. J Clin Oncol. 29:4129–4136. 2011.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Almond RJ, Flanagan BF, Antonopoulos A,
Haslam SM, Dell A, Kimber I and Dearman RJ: Differential
immunogenicity and allergenicity of native and recombinant human
lactoferrins: Role of glycosylation. Eur J Immunol. 43:170–181.
2013.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Lonnerdal B, Jiang R and Du X: Bovine
lactoferrin can be taken up by the human intestinal lactoferrin
receptor and exert bioactivities. J Pediatr Gastroenterol Nutr.
53:606–614. 2011.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Davidson LA and Lonnerdal B: Persistence
of human milk proteins in the breast-fed infant. Acta Paediatr
Scand. 76:733–740. 1987.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Wynn JL and Levy O: Role of innate host
defenses in susceptibility to early-onset neonatal sepsis. Clin
Perinatol. 37:307–337. 2010.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Lambert LA: Molecular evolution of the
transferrin family and associated receptors. Biochim Biophys Acta.
1820:244–255. 2012.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Peters T Jr: All about albumin.
Biochemistry, Genetics and Medical Applications. Academic Press,
Inc., San Diego, CA, 1996.
|
|
95
|
Fasano M, Fanali G, Leboffe L and Ascenzi
P: Heme binding to albuminoid proteins is the result of recent
evolution. IUBMB Life. 59:436–440. 2007.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Aisen P: Transferrin receptor 1. Int J
Biochem Cell Biol. 36:2137–2143. 2004.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Evans TW: Review article: Albumin as a
drug-biological effects of albumin unrelated to oncotic pressure.
Aliment Pharmacol Ther. 16 (Suppl 5):S6–S11. 2002.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Mendez CM, McClain CJ and Marsano LS:
Albumin therapy in clinical practice. Nutr Clin Pract. 20:314–320.
2005.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Gupta D and Lis CG: Pretreatment serum
albumin as a predictor of cancer survival: A systematic review of
the epidemiological literature. Nutr J. 9(69)2010.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Koga M and Kasayama S: Clinical impact of
glycated albumin as another glycemic control marker. Endocr J.
57:751–762. 2010.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Sbarouni E, Georgiadou P and Voudris V:
Ischemia modified albumin changes-review and clinical implications.
Clin Chem Lab Med. 49:177–184. 2011.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Marth E and Kleinhappl B: Albumin is a
necessary stabilizer of TBE-vaccine to avoid fever in children
after vaccination. Vaccine. 20:532–537. 2001.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Haynes GR, Navickis RJ and Wilkes MM:
Albumin administration-what is the evidence of clinical benefit? A
systematic review of randomized controlled trials. Eur J
Anaesthesiol. 20:771–793. 2003.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Alderson P, Bunn F, Lefebvre C, Li WP, Li
L, Roberts I and Schierhout G: Albumin Reviewers: Human albumin
solution for resuscitation and volume expansion in critically ill
patients. Cochrane Database Syst Rev. 2004(CD001208)2004.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Idzerda RL, Huebers H, Finch CA and
McKnight GS: Rat transferrin gene expression: Tissue-specific
regulation by iron deficiency. Proc Natl Acad Sci USA.
83:3723–3727. 1986.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Macedo MF and de Sousa M: Transferrin and
the transferrin receptor: Of magic bullets and other concerns.
Inflamm Allergy Drug Targets. 7:41–52. 2008.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Ingenbleek Y and Young V: Transthyretin
(prealbumin) in health and disease: Nutritional implications. Annu
Rev Nutr. 14:495–533. 1994.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Ballmer PE: Causes and mechanisms of
hypoalbuminaemia. Clin Nutr. 20:271–273. 2001.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Cynober L, Prugnaud O, Lioret N, Duchemin
C, Saizy R and Giboudeau J: Serum transthyretin levels in patients
with burn injury. Surgery. 109:640–644. 1991.PubMed/NCBI
|
|
110
|
Yang HT, Yim H, Cho YS, Kim D, Hur J, Kim
JH, Lee JW, Lee YK, Lee J, Han SW and Chun W: Serum transthyretin
level is associated with clinical severity rather than nutrition
status in massively burned patients. JPEN J Parenter Enteral Nutr.
38:966–972. 2014.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Le Bricon T, Guidet B, Coudray-Lucas C,
Staikowsky F, Gabillet JM, Offenstadt G, Giboudeau J and Cynober L:
Biochemical assessment of nutritional status in patients with
chronic obstructive pulmonary disease and acute respiratory failure
on admission to an intensive care unit. Clin Nutr. 13:98–104.
1994.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Germano Borges de Oliveira Nascimento
Freitas R, Negrao Nogueira RJ and Hessel G: Protein needs of
Critically Ill patients receiving parenteral nutrition. Nutr Hosp.
32:250–255. 2015.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Yu PJ, Cassiere HA, Dellis SL, Manetta F,
Kohn N and Hartman AR: Impact of preoperative prealbumin on
outcomes after cardiac surgery. JPEN J Parenter Enteral Nutr.
39:870–874. 2015.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Alsemgeest SP, Kalsbeek HC, Wensing T,
Koeman JP, van Ederen AM and Gruys E: Concentrations of serum
amyloid-A (SAA) and haptoglobin (HP) as parameters of inflammatory
diseases in cattle. Vet Q. 16:21–23. 1994.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Mills PC, Auer DE, Kramer H, Barry D and
Ng JC: Effects of inflammation-associated acute-phase response on
hepatic and renal indices in the horse. Aust Vet J. 76:187–194.
1998.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Mills PC, Ng JC and Auer DE: The effect of
inflammation on the disposition of phenylbutazone in thoroughbred
horses. J Vet Pharmacol Ther. 19:475–481. 1996.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Mills PC, Ng JC and Auer DE: The effect of
the acute-phase response on in vitro drug metabolism and plasma
protein binding in the horse. Vet Res Commun. 21:361–368.
1997.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Jacobsen S, Andersen PH, Toelboell T and
Heegaard PM: Dose dependency and individual variability of the
lipopolysaccharide-induced bovine acute phase protein response. J
Dairy Sci. 87:3330–3339. 2004.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Araujo LM, Ribeiro OG, Siqueira M, De
Franco M, Starobinas N, Massa S, Cabrera WH, Mouton D, Seman M and
Ibañez OM: Innate resistance to infection by intracellular
bacterial pathogens differs in mice selected for maximal or minimal
acute inflammatory response. Eur J Immunol. 28:2913–2920.
1998.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Verschuur M, van der Beek MT, Tak HS,
Visser LG and de Maat MP: Interindividual variation in the response
by fibrinogen, C-reactive protein and interleukin-6 to yellow fever
vaccination. Blood Coagul Fibrinolysis. 15:399–404. 2004.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Elsasser TH, Blum JW and Kahl S:
Characterization of calves exhibiting a novel inheritable TNF-alpha
hyperresponsiveness to endotoxin: Associations with increased
pathophysiological complications. J Appl Physiol (1985).
98:2045–2055. 2005.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Park HL, Shim SH, Lee EY, Cho W, Park S,
Jeon HJ, Ahn SY, Kim H and Nam JH: Obesity-induced chronic
inflammation is associated with the reduced efficacy of influenza
vaccine. Hum Vaccin Immunother. 10:1181–1186. 2014.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Frasca D, Ferracci F, Diaz A, Romero M,
Lechner S and Blomberg BB: Obesity decreases B cell responses in
young and elderly individuals. Obesity (Silver Spring). 24:615–625.
2016.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Lisciandro JG and van den Biggelaar AH:
Neonatal immune function and inflammatory illnesses in later life:
Lessons to be learnt from the developing world? Clin Exp Allergy.
40:1719–1731. 2010.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Eckersall PD, Lawson FP, Bence L,
Waterston MM, Lang TL, Donachie W and Fontaine MC: Acute phase
protein response in an experimental model of ovine caseous
lymphadenitis. BMC Vet Res. 3(35)2007.PubMed/NCBI View Article : Google Scholar
|
|
126
|
EL-Deeb WM and El-Bahr SM: Selected
biochemical indicators of equine rhabdomyolysis in Arabian horses:
Acute phase proteins and trace elements. Equine Vet Sci.
34:484–488. 2014. View Article : Google Scholar
|
|
127
|
EL-Deeb WM, El-Moslemany AM and Salem MA:
Cardiac troponin I and immune inflammatory response in horses with
strangles. Equine Vet Sci. 51:18–23. 2017. View Article : Google Scholar
|
|
128
|
Jones SA: Directing transition from innate
to acquired immunity: Defining a role for IL-6. J Immunol.
175:3463–3468. 2005.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Chomarat P, Banchereau J, Davoust J and
Palucka AK: IL-6 switches the differentiation of monocytes from
dendritic cells to macrophages. Nat Immunol. 1:510–514.
2000.PubMed/NCBI View
Article : Google Scholar
|
|
130
|
van der Beek MT, Visser LG and de Maat MP:
Yellow fever vaccination as a model to study the response to
stimulation of the inflammation system. Vascul Pharmacol.
39:117–121. 2002.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Kurtz SL, Foreman O, Bosio CM, Anver MR
and Elkins KL: Interleukin-6 is essential for primary resistance to
Francisella tularensis live vaccine strain infection. Infect Immun.
81:585–597. 2013.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Tsai MY, Hanson NQ, Straka RJ, Hoke TR,
Ordovas JM, Peacock JM, Arends VL and Arnett DK: Effect of
influenza vaccine on markers of inflammation and lipid profile. J
Lab Clin Med. 145:323–327. 2005.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Posthouwer D, Voorbij HA, Grobbee DE,
Numans ME and van der Bom JG: Influenza and pneumococcal
vaccination as a model to assess C-reactive protein response to
mild inflammation. Vaccine. 23:362–365. 2004.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Treanor JJ, Taylor DN, Tussey L, Hay C,
Nolan C, Fitzgerald T, Liu G, Kavita U, Song L, Dark I and Shaw A:
Safety and immunogenicity of a recombinant hemagglutinin
influenza-flagellin fusion vaccine (VAX125) in healthy young
adults. Vaccine. 28:8268–8274. 2010.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Njoroge L, Khayata M, Zacharias M and
ElAmm C: Acute myocarditis following influenza vaccine in a heart
transplant patient. J Cardiac Failure. 24 (Suppl):S45–S46. 2018.
View Article : Google Scholar
|
|
136
|
Garcon N, Leroux-Roels G and Cheng W:
Vaccine adjuvants. In: Understanding Modern Vaccines: Perspectives
in Vaccinology: Elsevier, pp89-113, 2011.
|
|
137
|
Mutwiri G, Gerdts V, van Drunen Littel-van
den Hurk S, Auray G, Eng N, Garlapati S, Babiuk LA and Potter A:
Combination adjuvants: The next generation of adjuvants? Expert Rev
Vaccines. 10:95–107. 2011.PubMed/NCBI View Article : Google Scholar
|
|
138
|
Singh M, Ugozzoli M, Kazzaz J, Chesko J,
Soenawan E, Mannucci D, Titta F, Contorni M, Volpini G, Del Guidice
G and O'Hagan DT: A preliminary evaluation of alternative adjuvants
to alum using a range of established and new generation vaccine
antigens. Vaccine. 24:1680–1686. 2006.PubMed/NCBI View Article : Google Scholar
|
|
139
|
Leroux-Roels G: Unmet needs in modern
vaccinology: Adjuvants to improve the immune response. Vaccine. 28
(Suppl 3):C25–C36. 2010.PubMed/NCBI View Article : Google Scholar
|
|
140
|
Destexhe E, Prinsen MK, van Schöll I,
Kuper CF, Garçon N, Veenstra S and Segal L: Evaluation of
C-reactive protein as an inflammatory biomarker in rabbits for
vaccine nonclinical safety studies. J Pharmacol Toxicol Methods.
68:367–373. 2013.PubMed/NCBI View Article : Google Scholar
|
|
141
|
El Yousfi M, Mercier S, Breuillé D, Denis
P, Papet I, Mirand PP and Obled C: The inflammatory response to
vaccination is altered in the elderly. Mech Ageing Dev.
126:874–881. 2005.PubMed/NCBI View Article : Google Scholar
|
|
142
|
Liuba P, Aburawi EH, Pesonen E, Andersson
S, Truedsson L, Ylä-Herttuala S and Holmberg L: Residual adverse
changes in arterial endothelial function and LDL oxidation after a
mild systemic inflammation induced by influenza vaccination. Ann
Med. 39:392–399. 2007.PubMed/NCBI View Article : Google Scholar
|
|
143
|
He R, Shepard LW, Chen J, Pan ZK and Ye
RD: Serum amyloid A is an endogenous ligand that differentially
induces IL-12 and IL-23. J Immunol. 177:4072–4079. 2006.PubMed/NCBI View Article : Google Scholar
|
|
144
|
Lu P, Liu J and Pang X: Pravastatin
inhibits fibrinogen- and FDP-induced inflammatory response via
reducing the production of IL-6, TNF-alpha and iNOS in vascular
smooth muscle cells. Mol Med Rep. 12:6145–6151. 2015.PubMed/NCBI View Article : Google Scholar
|
|
145
|
Lazzaro M, Bettegazzi B, Barbariga M,
Codazzi F, Zacchetti D and Alessio M: Ceruloplasmin potentiates
nitric oxide synthase activity and cytokine secretion in activated
microglia. J Neuroinflammation. 11(164)2014.PubMed/NCBI View Article : Google Scholar
|
|
146
|
Martinez Cordero E, Gonzalez MM, Aguilar
LD, Orozco EH and Hernandez Pando R: Alpha-1-acid glycoprotein, its
local production and immunopathological participation in
experimental pulmonary tuberculosis. Tuberculosis (Edinb).
88:203–211. 2008.PubMed/NCBI View Article : Google Scholar
|
|
147
|
de Serres F and Blanco I: Role of alpha-1
antitrypsin in human health and disease. J Intern Med. 276:311–335.
2014.PubMed/NCBI View Article : Google Scholar
|
|
148
|
Haversen L, Ohlsson BG, Hahn-Zoric M,
Hanson LA and Mattsby-Baltzer I: Lactoferrin down-regulates the
LPS-induced cytokine production in monocytic cells via NF-kappa B.
Cell Immunol. 220:83–95. 2002.PubMed/NCBI View Article : Google Scholar
|
|
149
|
Du Clos TW: Function of C-reactive
protein. Ann Med. 32:274–278. 2000.PubMed/NCBI View Article : Google Scholar
|
|
150
|
Spadaro M, Montone M, Arigoni M,
Cantarella D, Forni G, Pericle F, Pascolo S, Calogero RA and
Cavallo F: Recombinant human lactoferrin induces human and mouse
dendritic cell maturation via Toll-like receptors 2 and 4. FASEB J.
28:416–429. 2014.PubMed/NCBI View Article : Google Scholar
|
|
151
|
Feelders RA, Vreugdenhil G, Eggermont AM,
Kuiper-Kramer PA, van Eijk HG and Swaak AJ: Regulation of iron
metabolism in the acute-phase response: Interferon gamma and tumour
necrosis factor alpha induce hypoferraemia, ferritin production and
a decrease in circulating transferrin receptors in cancer patients.
Eur J Clin Invest. 28:520–527. 1998.PubMed/NCBI View Article : Google Scholar
|
|
152
|
Bartalena L, Farsetti A, Flink IL and
Robbins J: Effects of interleukin-6 on the expression of thyroid
hormone-binding protein genes in cultured human
hepatoblastoma-derived (Hep G2) cells. Mol Endocrinol. 6:935–942.
1992.PubMed/NCBI View Article : Google Scholar
|
|
153
|
Louagie H, Delanghe J, Desombere I, De
Buyzere M, Hauser P and Leroux-Roels G: Haptoglobin polymorphism
and the immune response after hepatitis B vaccination. Vaccine.
11:1188–1190. 1993.PubMed/NCBI View Article : Google Scholar
|
|
154
|
Borthwick NJ, Lane T, Moyo N, Crook A,
Shim JM, Baines I, Wee EG, Hawkins PN, Gillmore JD, Hanke T and
Pepys MB: Randomized phase I trial HIV-CORE 003: Depletion of serum
amyloid P component and immunogenicity of DNA vaccination against
HIV-1. PLoS One. 13(e0197299)2018.PubMed/NCBI View Article : Google Scholar
|
|
155
|
Creech CB, Frenck RW Jr, Sheldon EA,
Seiden DJ, Kankam MK, Zito ET, Girgenti D, Severs JM, Immermann FW,
McNeil LK, et al: Safety, tolerability, and immunogenicity of a
single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in
healthy older adults: Results of a randomised trial. Vaccine.
35:385–394. 2017.PubMed/NCBI View Article : Google Scholar
|
|
156
|
Blom M, Prag JB and Norredam K: Alpha
1-Acid glycoprotein, alpha 1-antitrypsin, and ceruloplasmin in
human intestinal helminthiases. Am J Trop Med Hyg. 28:76–83.
1979.PubMed/NCBI View Article : Google Scholar
|
|
157
|
Naylor C, Lu M, Haque R, Mondal D, Buonomo
E, Nayak U, Mychaleckyj JC, Kirkpatrick B, Colgate R, Carmolli M,
et al: Environmental enteropathy, oral vaccine failure and growth
faltering in infants in bangladesh. EBioMedicine. 2:1759–1766.
2015.PubMed/NCBI View Article : Google Scholar
|
|
158
|
Hwang SA, Kruzel ML and Actor JK:
Lactoferrin augments BCG vaccine efficacy to generate T helper
response and subsequent protection against challenge with virulent
Mycobacterium tuberculosis. Int Immunopharmacol. 5:591–599.
2005.PubMed/NCBI View Article : Google Scholar
|
|
159
|
Carty CL, Heagerty P, Nakayama K, McClung
EC, Lewis J, Lum D, Boespflug E, McCloud-Gehring C, Soleimani BR,
Ranchalis J, et al: Inflammatory response after influenza
vaccination in men with and without carotid artery disease.
Arterioscler Thromb Vasc Biol. 26:2738–2744. 2006.PubMed/NCBI View Article : Google Scholar
|
|
160
|
Patel C and Shah HH: Membranous
nephropathy and severe acute kidney injury following influenza
vaccination. Saudi J Kidney Dis Transpl. 26:1289–1293.
2015.PubMed/NCBI View Article : Google Scholar
|
|
161
|
Bos MP, Poolman J, Stork M, Tommassen JPM
and Weynants V: Vaccine comprising protein NMB0964 from
Neisseria meningitidis. US Patent 9,259,461. Filed March 6,
2009; issued August 4, 2011.
|
